Skip to main content
CAMP logo

CAMP · Camp4 Therapeutics Corp · Investor Relations

Track CAMP — free
$4.00 +0.14 (+3.63%) Q3 2024 earnings call transcript
Market Cap
$242.23M
Shares
62.75M
Volume · Nov 17 131.09K Avg daily vol (3M) 246.59K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Past events

Date Event Type
2026-11-10 Stifel 2026 Healthcare Conference Conference
2026-11-09 Guggenheim 3rd Annual Healthcare Innovation Conference Conference
2026-10-20 Chardan's 10th Annual Healthcare Conference Conference
2026-09-28 CAMP4 Therapeutics Virtual Analyst Event Webcast
2026-09-09 Cantor Global Healthcare Conference 2026 Conference
2026-06-10 2026 Annual Meeting of Stockholders Shareholder meeting
2026-05-19 H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ Conference
2026-04-13 Needham & Company, LLC 25th Annual Healthcare Conference Conference
2026-03-17 Stifel CNS Forum Webcast
2026-03-09 Leerink Partners Global Healthcare Conference Conference
2026-01-14 J.P. Morgan 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-03 Piper Sandler 37th Annual Healthcare Conference Conference
2025-10-21 Chardan's 9th Annual Genetic Medicines Conference Conference
2025-09-03 Cantor Global Healthcare Conference 2025 Conference
2025-06-11 2025 Annual Meeting of Stockholders Shareholder meeting
2025-05-16 28th Annual American Society of Gene and Cell Therapy (ASGCT) Meeting Event
2025-04-09 24th Annual Needham Virtual Healthcare Conference Conference
2025-03-11 Barclays 27th Annual Global Healthcare Conference Conference
2025-03-10 Leerink Partners Global Healthcare Conference Conference
2025-02-12 Oppenheimer’s 35th Annual Healthcare Life Sciences Conference Conference
2025-01-15 43rd Annual J.P. Morgan Healthcare Conference Conference
2024-12-05 Piper Sandler 36th Annual Healthcare Conference Conference

Source: https://investors.camp4tx.com/

Key facts CIK 1736730 CUSIP 13463J101 13F (30d) 69 filings 66 filers Visit website Investor relations